Wugen is a clinical stage immuno-oncology cell therapy company, developing off-the-shelf NK and CAR-T cell therapies for the treatment of both solid tumor and heme malignancies.


Biotechnology

Wugen

Kumar Srinivasan

Keith Vendola

Jimmy Pham

Carol Weiss

Sarah Perdue

Patrick Valme

Kenneth Jacobs

Chupei Zhang

Rachel Langland

Preeta Dasgupta

Matthew Cooper

Laura Simpson PhD

Jonathan Miller

Brunda Tumala

Jan Davidson

Ayman Kabakibi

Research and Development Scientists

Clinical and Regulatory Affairs

Leadership Team

Research and Development

Finance and Operations

Advisory Roles

Teams at Wugen

Research and Development Scientists

Clinical and Regulatory Affairs

Leadership Team

Research and Development

Finance and Operations

Advisory Roles